Ubs Group Ag Innoviva, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Innoviva, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 308,346 shares of INVA stock, worth $5.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

308,346

Previous 278,904 10.56%

Holding current value

$5.9 Million

Previous $4.57 Million 30.1%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $480,787 - $590,017	29,442 Added 10.56%	308,346 $5.95 Million
Q2 2024 Aug 13, 2024	SELL	$14.4 - $16.4 $3.79 Million - $4.32 Million	-263,392 Reduced 48.57%	278,904 $4.57 Million
Q1 2024 May 13, 2024	BUY	$14.56 - $16.78 $2.69 Million - $3.1 Million	184,637 Added 51.62%	542,296 $8.26 Million
Q4 2023 Feb 09, 2024	SELL	$12.32 - $16.27 $3.31 Million - $4.37 Million	-268,696 Reduced 42.9%	357,659 $5.74 Million
Q3 2023 Nov 09, 2023	BUY	$12.37 - $13.89 $5.36 Million - $6.01 Million	432,940 Added 223.84%	626,355 $8.14 Million
Q2 2023 Aug 11, 2023	SELL	$11.39 - $13.72 $2.67 Million - $3.22 Million	-234,814 Reduced 54.83%	193,415 $2.46 Million
Q1 2023 May 12, 2023	SELL	$10.73 - $13.6 $381,590 - $483,656	-35,563 Reduced 7.67%	428,229 $4.82 Million
Q4 2022 Feb 08, 2023	BUY	$11.8 - $13.78 $5.21 Million - $6.08 Million	441,243 Added 1956.82%	463,792 $6.15 Million
Q3 2022 Nov 10, 2022	SELL	$11.61 - $15.22 $7.14 Million - $9.36 Million	-614,856 Reduced 96.46%	22,549 $261,000
Q2 2022 Aug 10, 2022	SELL	$14.32 - $19.88 $92,922 - $129,001	-6,489 Reduced 1.01%	637,405 $9.41 Million
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $1.91 Million - $2.51 Million	123,790 Added 23.8%	643,894 $12.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $1.89 Million - $2.23 Million	119,070 Added 29.69%	520,104 $8.97 Million
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $2.36 Million - $3.11 Million	-180,453 Reduced 31.03%	401,034 $6.7 Million
Q2 2021 Aug 13, 2021	SELL	$11.45 - $13.96 $881,455 - $1.07 Million	-76,983 Reduced 11.69%	581,487 $7.8 Million
Q1 2021 May 12, 2021	SELL	$11.06 - $12.87 $2.02 Million - $2.36 Million	-183,084 Reduced 21.76%	658,470 $7.87 Million
Q4 2020 Feb 11, 2021	BUY	$9.33 - $12.48 $6.23 Million - $8.33 Million	667,417 Added 383.27%	841,554 $10.4 Million
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $3.61 Million - $5.07 Million	-349,625 Reduced 66.75%	174,137 $1.82 Million
Q2 2020 Jul 31, 2020	BUY	$11.49 - $15.26 $56,553 - $75,109	4,922 Added 0.95%	523,762 $7.32 Million
Q1 2020 May 01, 2020	BUY	$8.11 - $15.23 $1.3 Million - $2.44 Million	159,967 Added 44.57%	518,840 $6.1 Million
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $2.5 Million - $3.5 Million	-243,468 Reduced 40.42%	358,873 $5.08 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $3.7 Million - $5.35 Million	367,900 Added 156.93%	602,341 $6.35 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $767,227 - $875,576	-58,567 Reduced 19.99%	234,441 $3.41 Million
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $1.06 Million - $1.55 Million	-77,453 Reduced 20.91%	293,008 $4.11 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $5.09 Million - $6.66 Million	364,488 Added 6102.26%	370,461 $6.47 Million
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $16.7 Million - $19.2 Million	-1,223,876 Reduced 99.51%	5,973 $91,000
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $7.01 Million - $9.17 Million	521,515 Added 73.63%	1,229,849 $17 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.99 $7.26 Million - $8.93 Million	525,859 Added 288.18%	708,334 $11.8 Million
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $1.22 Million - $1.53 Million	104,058 Added 132.7%	182,475 $2.59 Million
Q3 2017 Nov 14, 2017	SELL	$12.06 - $14.12 $1.13 Million - $1.32 Million	-93,629 Reduced 54.42%	78,417 $1.11 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,182 Added 20.43%	172,046 $2.2 Million
Q1 2017 Nov 14, 2017	BUY	N/A	142,864	142,864 $1.98 Million

Others Institutions Holding INVA

# of Institutions

229

Shares Held

79.2M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account